Nelarabine Injection
Product Images NDC 70710-1726

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nelarabine (NDC 70710-1726). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (C413382e 8621 4c5a 940e 61e7a285286f 01)

FDA Label Image

Container (C413382e 8621 4c5a 940e 61e7a285286f 02)

FDA Label Image

1's Carton (C413382e 8621 4c5a 940e 61e7a285286f 03)

1's Carton (C413382e 8621 4c5a 940e 61e7a285286f 03)
This is a description of Nelarabine, an injection administered via intravenous infusion. This drug is available in a 250mg/50 single-dose vial and contains 5mg/mL Nelarabine. Any unused portion should be discarded. The manufacturer of the drug is not available due to poor text quality.*
FDA Label Image

Carton (C413382e 8621 4c5a 940e 61e7a285286f 04)

Carton (C413382e 8621 4c5a 940e 61e7a285286f 04)
Nelarabine Injection is a medication delivered through intravenous infusion. The container holds 250mg/50mL of medication that is for single-use only. Any unused portion should be discarded.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.